Evidence map›Paper›PMID 35564662›Full record

ArticleInternational journal of environmental research and public health2022

Applicability of Novel Urinary Biomarkers for the Assessment of Renal Injury in Selected Occupational Groups in Sri Lanka: A Comparative Study with Conventional Markers.

E M D V Ekanayake, T D K S C Gunasekara, P Mangala C S De Silva, Sudheera Jayasinghe, E P S Chandana, Nishad Jayasundara

Open access · goldAbstract readComparative Study
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

E M D V EkanayakeDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58203, USA.
T D K S C GunasekaraDepartment of Zoology, Faculty of Science, University of Ruhuna, Matara 81000, Sri Lanka.ORCID 0000-0002-3095-6164
P Mangala C S De SilvaDepartment of Zoology, Faculty of Science, University of Ruhuna, Matara 81000, Sri Lanka.ORCID 0000-0002-1927-6512
Sudheera JayasingheDepartment of Pharmacology, Faculty of Medicine, University of Ruhuna, Galle 80000, Sri Lanka.
E P S ChandanaDepartment of Biosystems Technology, Faculty of Technology, University of Ruhuna, Matara 81000, Sri Lanka.
Nishad JayasundaraThe Nicholas School of the Environment, Duke University, Durham, NC 27708, USA.ORCID 0000-0003-2485-6893
University of Ruhuna · LKDuke University · USUniversity of North Dakota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Screening approaches with more robust biomarkers, are of the utmost importance in the characterization of renal injuries, particularly among communities with high burdens of chronic kidney disease of uncertain etiology (CKDu). The present study aimed to assess the utility of two emerging biomarkers: kidney injury molecule (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) in predicting renal injury in different occupational groups in Sri Lanka. A cross-sectional study was conducted with six occupational groups (

Indexed as

KidneyRenal Insufficiency, ChronicBiomarkersCross-Sectional StudiesHepatitis A Virus Cellular Receptor 1HumansLipocalin-2Sri LankaBiomarkersHepatitis A Virus Cellular Receptor 1Lipocalin-2biomarkersearly diagnosiskidney diseasesmass screeningoccupational groups

Identifiers

PMID35564662
PMCPMC9099841
OpenAlexW4224988062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.